A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
Clinical trial NCT01342679 · COMPLETED
Trial details
- NCT number
- NCT01342679
- Sponsor
- Kanto CML Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-03-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.